{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:36:28Z","timestamp":1790516188305,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.ygyno.2017.02.006","type":"journal-article","created":{"date-parts":[[2017,2,13]],"date-time":"2017-02-13T14:36:55Z","timestamp":1486996615000},"page":"148-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Long-term ototoxicity in women after cisplatin treatment for ovarian germ cell cancer"],"prefix":"10.1016","volume":"145","author":[{"given":"Jakob","family":"Skalleberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olesya","family":"Solheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie D.","family":"Foss\u00e5","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milada Cvancarova","family":"Sm\u00e5stuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terje","family":"Osnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per Ole M.","family":"Gundersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Bunne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ygyno.2017.02.006_bb0005","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1200\/JCO.1996.14.11.2923","article-title":"Evaluation of long-term toxicity after chemotherapy for testicular cancer","volume":"14","author":"Bokemeyer","year":"1996","journal-title":"J. Clin. Oncol."},{"issue":"34","key":"10.1016\/j.ygyno.2017.02.006_bb0010","doi-asserted-by":"crossref","first-page":"8588","DOI":"10.1200\/JCO.2004.00.5355","article-title":"Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may influence academic and social development","volume":"23","author":"Knight","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.ygyno.2017.02.006_bb0015","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1200\/JCO.2006.07.9723","article-title":"Early changes in auditory function as a result of platinum chemotherapy: use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions","volume":"25","author":"Knight","year":"2007","journal-title":"J. Clin. Oncol."},{"issue":"19","key":"10.1016\/j.ygyno.2017.02.006_bb0020","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1200\/JCO.2011.39.1110","article-title":"Platinum-induced ototoxicity in children: a consensus review on mechanisms, predisposition, and protection, including a new International Society of Pediatric Oncology Boston ototoxicity scale","volume":"30","author":"Brock","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.ygyno.2017.02.006_bb0025","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2217\/pgs.11.48","article-title":"Pharmacogenomics of cisplatin-induced ototoxicity","volume":"12","author":"Mukherjea","year":"2011","journal-title":"Pharmacogenomics"},{"issue":"10","key":"10.1016\/j.ygyno.2017.02.006_bb0030","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/01.mph.0000141348.62532.73","article-title":"Platinum compound-related ototoxicity in children: long-term follow-up reveals continuous worsening of hearing loss","volume":"26","author":"Bertolini","year":"2004","journal-title":"J. Pediatr. Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2017.02.006_bb0035","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/hed.23551","article-title":"Sensorineural hearing loss in patients with head and neck cancer after chemoradiotherapy and radiotherapy: a systematic review of the literature","volume":"37","author":"Theunissen","year":"2015","journal-title":"Head Neck"},{"issue":"9904","key":"10.1016\/j.ygyno.2017.02.006_bb0040","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/S0140-6736(13)60142-7","article-title":"Tinnitus","volume":"382","author":"Baguley","year":"2013","journal-title":"Lancet."},{"issue":"6","key":"10.1016\/j.ygyno.2017.02.006_bb0045","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1200\/JCO.2006.08.9599","article-title":"Cisplatin-induced long-term hearing impairment is associated with specific glutathione s-transferase genotypes in testicular cancer survivors","volume":"25","author":"Oldenburg","year":"2007","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2017.02.006_bb0050","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1200\/JCO.2011.37.4025","article-title":"Impact of long-term serum platinum concentrations on neuro- and ototoxicity in cisplatin-treated survivors of testicular cancer","volume":"30","author":"Sprauten","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2017.02.006_bb0055","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2016.66.8822","article-title":"Comprehensive audiometric analysis of hearing impairment and tinnitus after cisplatin-based chemotherapy in survivors of adult-onset cancer","author":"Frisina","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.ygyno.2017.02.006_bb0060","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1002\/cncr.24981","article-title":"Long-term neurologic and peripheral vascular toxicity after chemotherapy treatment of testicular cancer","volume":"116","author":"Glendenning","year":"2010","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2017.02.006_bb0065","first-page":"1619","article-title":"Long-term platinum retention after platinum-based chemotherapy in testicular cancer survivors: a 20-year follow-up study","volume":"35","author":"Hjelle","year":"2015","journal-title":"Anticancer Res."},{"issue":"10","key":"10.1016\/j.ygyno.2017.02.006_bb0070","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1007\/s00405-014-3283-0","article-title":"Is there a gender-related susceptibility for cisplatin ototoxicity?","volume":"272","author":"Kirkim","year":"2015","journal-title":"Eur. Arch. Otorhinolaryngol."},{"issue":"1","key":"10.1016\/j.ygyno.2017.02.006_bb0075","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/pbc.24138","article-title":"Risk factors for cisplatin-associated ototoxicity in pediatric oncology patients","volume":"59","author":"Yancey","year":"2012","journal-title":"Pediatr. Blood Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2017.02.006_bb0080","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ygyno.2014.12.010","article-title":"Fertility and gonadal function after adjuvant therapy in women diagnosed with a malignant ovarian germ cell tumor (MOGCT) during the \u201ccisplatin era\u201d","volume":"136","author":"Solheim","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"8","key":"10.1016\/j.ygyno.2017.02.006_bb0085","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0959-8049(03)00152-7","article-title":"Lack of impact of platinum dose intensity on the outcome of ovarian cancer patients. 10-year results of a prospective randomised phase III study comparing carboplatin-cisplatin with cyclophosphamide-cisplatin","volume":"39","author":"Dittrich","year":"2003","journal-title":"Eur. J. Cancer"},{"issue":"5","key":"10.1016\/j.ygyno.2017.02.006_bb0090","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s11136-005-5370-6","article-title":"Scale for chemotherapy-induced long-term neurotoxicity (SCIN): psychometrics, validation, and findings in a large sample of testicular cancer survivors","volume":"15","author":"Oldenburg","year":"2006","journal-title":"Qual. Life Res."},{"issue":"2","key":"10.1016\/j.ygyno.2017.02.006_bb0095","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1001\/archotol.1996.01890140029007","article-title":"Development of the tinnitus handicap inventory","volume":"122","author":"Newman","year":"1996","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"issue":"5","key":"10.1016\/j.ygyno.2017.02.006_bb0100","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1046\/j.1365-2273.2001.00490.x","article-title":"Guidelines for the grading of tinnitus severity: the results of a working group commissioned by the British Association of Otolaryngologists, head and neck surgeons, 1999","volume":"26","author":"McCombe","year":"2001","journal-title":"Clin. Otolaryngol. Allied Sci."},{"issue":"28","key":"10.1016\/j.ygyno.2017.02.006_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/1463-1741.31632","article-title":"The Nord-Trondelag Norway audiometric survey 1996-98: unscreened thresholds and prevalence of hearing impairment for adults >20years","volume":"7","author":"Borchgrevink","year":"2005","journal-title":"Noise Health"},{"issue":"4","key":"10.1016\/j.ygyno.2017.02.006_bb0110","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/14992020500057731","article-title":"Screened and unscreened hearing threshold levels for the adult population: results from the Nord-Trondelag hearing loss study","volume":"44","author":"Engdahl","year":"2005","journal-title":"Int. J. Audiol."},{"issue":"9491","key":"10.1016\/j.ygyno.2017.02.006_bb0115","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0140-6736(05)67423-5","article-title":"Presbycusis","volume":"366","author":"Gates","year":"2005","journal-title":"Lancet."},{"issue":"23","key":"10.1016\/j.ygyno.2017.02.006_bb0120","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1200\/JCO.2016.68.2476","article-title":"The sound of silence: a proxy for platinum toxicity","volume":"34","author":"Oldenburg","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2017.02.006_bb0125","doi-asserted-by":"crossref","first-page":"1809394","DOI":"10.1155\/2016\/1809394","article-title":"Cisplatin-associated ototoxicity: a review for the health professional","volume":"2016","author":"Paken","year":"2016","journal-title":"J. Toxicol."},{"issue":"4","key":"10.1016\/j.ygyno.2017.02.006_bb0130","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/ije\/18.4.911","article-title":"The prevalence of hearing impairment and reported hearing disability among adults in great Britain","volume":"18","author":"Davis","year":"1989","journal-title":"Int. J. Epidemiol."},{"issue":"11","key":"10.1016\/j.ygyno.2017.02.006_bb0135","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1093\/annonc\/mdv369","article-title":"Long-term exposure to circulating platinum is associated with late effects of treatment in testicular cancer survivors","volume":"26","author":"Boer","year":"2015","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ygyno.2017.02.006_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2016.06.012","article-title":"Associations between long-term serum platinum and neurotoxicity and ototoxicity, endocrine gonadal function, and cardiovascular disease in testicular cancer survivors","author":"Hjelle","year":"2016","journal-title":"Urol. Oncol."},{"issue":"30","key":"10.1016\/j.ygyno.2017.02.006_bb0145","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1200\/JCO.2013.50.3409","article-title":"Solid tumors after chemotherapy or surgery for testicular nonseminoma: a population-based study","volume":"31","author":"Fung","year":"2013","journal-title":"J. Clin. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825817301178?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825817301178?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T09:04:23Z","timestamp":1749978263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825817301178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0090825817301178"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2017.02.006","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term ototoxicity in women after cisplatin treatment for ovarian germ cell cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2017.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}